HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance

  • David L. Schwartz
  • , James Bankson
  • , Luc Bidaut
  • , Yi He
  • , Ryan Williams
  • , Robert Lemos
  • , Arun Kumar Thitai
  • , Junghwan Oh
  • , Andrei Volgin
  • , Suren Soghomonyan
  • , Hsin-Hsien Yeh
  • , Ryuichi Nishii
  • , Uday Mukhopadhay
  • , Mian Alauddin
  • , Ioseb Mushkudiani
  • , Norihito Kuno
  • , Sunil Krishnan
  • , William Bornman
  • , Stephen Y. Lai
  • , Garth Powis
  • John Hazle, Juri Gelovani

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Purpose: Hypoxia-inducible factor 1 (HIF-1) promotes cancer cell survival and tumor progression. The specific role played by HIF-1 and tumor-stromal interactions toward determining tumor resistance to radiation treatment remains undefined. We applied a multimodality preclinical imaging platform to mechanistically characterize tumor response to radiation, with a focus on HIF-1-dependent resistance pathways.

    Methods: C6 glioma and HN5 human squamous carcinoma cells were stably transfected with a dual HIF-1 signaling reporter construct (dxHRE-tk/eGFP-cmvRed2XPRT). Reporter cells were serially interrogated in vitro before and after irradiation as monolayer and multicellular spheroid cultures and as subcutaneous xenografts in nu/nu mice.

    Results: In vitro, single-dose irradiation of C6 and HN5 reporter cells modestly impacted HIF-1 signaling in normoxic monolayers and inhibited HIF-1 signaling in maturing spheroids. In contrast, irradiation of C6 or HN5 reporter xenografts with 8 Gy in vivo elicited marked upregulation of HIF-1 signaling and downstream proangiogenic signaling at 48 hours which preceded recovery of tumor growth. In situ ultrasound imaging and dynamic contrast-enhanced (DCE) MRI indicated that HIF-1 signaling followed acute disruption of stromal vascular function. High-resolution positron emission tomography and dual-contrast DCE-MRI of immobilized dorsal skin window tumors confirmed postradiotherapy HIF-1 signaling to spatiotemporally coincide with impaired stromal vascular function. Targeted disruption of HIF-1 signaling established this pathway to be a determinant of tumor radioresistance.

    Conclusions: Our results illustrate that tumor radioresistance is mediated by a capacity to compensate for stromal vascular disruption through HIF-1-dependent proangiogenic signaling and that clinically relevant vascular imaging techniques can spatially define mechanisms associated with tumor irradiation. Mol Cancer Res; 9(3); 259-70. (C) 2011 AACR.

    Original languageEnglish
    Pages (from-to)259-270
    Number of pages12
    JournalMolecular Cancer Research
    Volume9
    Issue number3
    DOIs
    Publication statusPublished - Mar 2011

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Inducible factor 1
    • Contrast enhanced sonography
    • Magnetic resonance
    • Cancer therapy
    • Dilated cardiomyopathy
    • Inhibitor PX-478
    • Gene expression
    • Hypoxia
    • HIF-1
    • Angiogenesis

    Fingerprint

    Dive into the research topics of 'HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance'. Together they form a unique fingerprint.

    Cite this